Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05211440 · ClinicalTrials.gov registry record · NA
Microbial Enzyme Impact on Postprandial Nutrient Levels and Gastrointestinal Symptoms in Healthy Adults
A NA study of Digestive Health and Gastrointestinal Health, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05211440: Completed NA study of Digestive Health and Gastrointestinal Health, sponsored by University of Illinois at Urbana-Champaign.
NCT05211440 is a NA study of Digestive Health and Gastrointestinal Health that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 30 participants, below the 78-participant average among 6 other Digestive Health trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05211440, a NA study of Digestive Health and Gastrointestinal Health, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to investigate the acute effects of a microbial multi-enzyme mixture ("BC-006") on postprandial nutrient levels in healthy, middle-aged to older adults during a mixed meal tolerance test. Additionally, the effects of twice daily consumption of BC-006 and placebo for 3 weeks on abdominal bloating, flatulence, bowel function, and sleep quality will be measured.
Primary Outcome
Free leucine, isoleucine, valine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan (combined), change from baseline (BC-006 vs. placebo treatment)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo + Meal
- DIETARY_SUPPLEMENT BC-006 + Meal
Study Locations (1)
Illinois
- Freer Hall - Urbana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-01-18 |
| Est. Completion | 2023-08-25 |
| Phase | NA |
What the finished NCT05211440 record still lists
NCT05211440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 78-participant average among 6 other Digestive Health trials with a reported enrollment target (62% lower).
The record links to 2 conditions, with Digestive Health appearing as the primary indexed condition, and to 2 interventions - of which Placebo + Meal is the first listed.
NCT05211440 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05211440 about?
NCT05211440 is a clinical study titled "Microbial Enzyme Impact on Postprandial Nutrient Levels and Gastrointestinal Symptoms in Healthy Adults". The primary objective of this study is to investigate the acute effects of a microbial multi-enzyme mixture ("BC-006") on postprandial nutrient levels in healthy, middle-aged to older adults during a mixed meal tolerance test. Additionally, the effects of twice daily consumption of BC-006 and placeb...
What is the current status of trial NCT05211440?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-01-18. Estimated completion is 2023-08-25.
What conditions does trial NCT05211440 study?
This clinical trial studies the following conditions: Digestive Health, Gastrointestinal Health.
What interventions are being tested in trial NCT05211440?
The interventions under investigation include: Placebo + Meal (DIETARY_SUPPLEMENT), BC-006 + Meal (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05211440?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05211440 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Digestive Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System
RECRUITING · NA
-
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
RECRUITING · NA
-
The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults
COMPLETED · NA
-
Protein-Prebiotic Wellbeing Study
COMPLETED · NA
-
Investigating the Tolerability of Oat Fiber (BG-OS) in Healthy Individuals
COMPLETED · NA
-
Alii Supplement Study
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI